Minoryx Therapeutics has appointed Didier Le Normand as group Chief Financial Officer (CFO) as well as general manager of its recently opened Belgian subsidiary.
Le Normand started his career in banking in the US and France and then established a long international career in finance and operations as well as M&A transactions for private and listed companies, particularly in the healthcare and technology sectors. He was CFO at STAT-DX, a Catalan diagnostics company solded to Qiagen in 2018.
Photo: Didier Le Normand - © Minoryx Therapeutics
Comments